A 6-month, open-label clinical trial of pancrelipase delayed-release capsules (Creon) in patients with exocrine pancreatic insufficiency due to chronic pancreatitis or pancreatic surgery

Alimentary Pharmacology and Therapeutics

Volumn 33, Issue 10, 2011, Pages 1152-1161

  Gubergrits, N ^a   Malecka Panas, E ^b   Lehman, G A ^c   Vasileva, G ^d   Shen, Y ^e   Sander Struckmeier, S ^f   Caras, S ^g   Whitcomb, D C ^g  

^a DONETSK NATIONAL MEDICAL UNIVERSITY   (Ukraine)

^b MEDICAL UNIVERSITY OF LODZ   (Poland)

^c INDIANA UNIVERSITY MEDICAL CENTER   (United States)

^d MHAT Rousse AD ^*  (Bulgaria)

^e ABBOTT LABORATORIES   (United States)

^f ABBOTT GMBH AND CO KG   (Germany)

^g UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

KREON; PANCRELIPASE; PLACEBO;

ABDOMINAL DISTENSION; ABDOMINAL PAIN; ACUTE PANCREATITIS; ADULT; ANEMIA; ARTICLE; ATELECTASIS; BILE DUCT DILATATION; BODY WEIGHT; BRONCHITIS; BURN; CHRONIC PANCREATITIS; CONTROLLED STUDY; DEFECATION HABIT; DELAYED DRUG RELEASE; DIABETES MELLITUS; DIABETIC FOOT; DIARRHEA; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG FEVER; DRUG SAFETY; DRUG WITHDRAWAL; FECES ANALYSIS; FEMALE; FEMUR FRACTURE; FLATULENCE; GASTROINTESTINAL DISEASE; HEMORRHOID; HERPES ZOSTER; HUMAN; MAJOR CLINICAL STUDY; MALE; OPEN STUDY; OUTCOME ASSESSMENT; PANCREAS EXOCRINE INSUFFICIENCY; PANCREAS SURGERY; PANCREATIC ENZYME REPLACEMENT THERAPY; PANCREATITIS; PRIORITY JOURNAL; QUALITY OF LIFE; RHINOPHARYNGITIS; SIDE EFFECT; SINUSITIS; STEATORRHEA; SUBSTITUTION THERAPY; TONSILLITIS; TREATMENT DURATION; UPPER RESPIRATORY TRACT INFECTION; URINARY TRACT INFECTION; WEIGHT; XEROSTOMIA;

ADULT; CAPSULES; DELAYED-ACTION PREPARATIONS; DOUBLE-BLIND METHOD; EXOCRINE PANCREATIC INSUFFICIENCY; FEMALE; GASTROINTESTINAL AGENTS; HUMANS; MALE; MIDDLE AGED; PANCREAS; PANCREATITIS, CHRONIC; PANCRELIPASE; TIME FACTORS; TREATMENT OUTCOME; WEIGHT GAIN;

EID: 79954836120     PISSN: 02692813     EISSN: 13652036     Source Type: Journal    
DOI: 10.1111/j.1365-2036.2011.04631.x     Document Type: Article

References (39)

1. Nair RJ, Lawler L, Miller MR,. Chronic pancreatitis. Am Fam Physician 2007; 76: 1679-88.
2. Abdel Aziz AM, Lehman GA,. Current treatment options for chronic pancreatitis. Curr Treat Options Gastroenterol 2007; 10: 355-68. (Pubitemid 47559350)
3. Khalid A, Whitcomb DC,. Conservative treatment of chronic pancreatitis. Eur J Gastroenterol Hepatol 2002; 14: 943-9.
4. Dumasy V, Delhaye M, Cotton F, Deviere J,. Fat malabsorption screening in chronic pancreatitis. Am J Gastroenterol 2004; 99: 1350-4. (Pubitemid 39062275)
5. Van Hoozen CM, Peeke PG, Taubeneck M, Frey CF, Halsted CH,. Efficacy of enzyme supplementation after surgery for chronic pancreatitis. Pancreas 1997; 14: 174-80. (Pubitemid 27106105)
6. Layer P, Keller J, Lankisch PG,. Pancreatic enzyme replacement therapy. Curr Gastroenterol Rep 2001; 3: 101-8.
7. Friess H, Böhm J, Müller MW, et al. Maldigestion after total gastrectomy is associated with pancreatic insufficiency. Am J Gastroenterol 1996; 91: 341-7. (Pubitemid 26067346)
8. Evans JD, Wilson PG, Carver C, et al. Outcome of surgery for chronic pancreatitis. Br J Surg 1997; 84: 624-9. (Pubitemid 27208280)
9. Kahl S, Malfertheiner P,. Exocrine and endocrine pancreatic insufficiency after pancreatic surgery. Best Pract Res Clin Gastroenterol 2004; 18: 947-55. (Pubitemid 39378181)
10. Ghaneh P, Neoptolemos JP,. Exocrine pancreatic function following pancreatectomy. Ann N Y Acad Sci 1999; 880: 308-18. (Pubitemid 29349138)
11. Domínguez-Muñoz JE,. Pancreatic enzyme therapy for pancreatic exocrine insufficiency. Curr Gastroenterol Rep 2007; 9: 116-22. (Pubitemid 46647523)
12. Ammann RW, Akovbiantz A, Largiader F, Schueler G,. Course and outcome of chronic pancreatitis. Longitudinal study of a mixed medical-surgical series of 245 patients. Gastroenterology 1984; 86: 820-8. (Pubitemid 14132461)
13. Ammann RW, Muellhaupt B,. The natural history of pain in alcoholic chronic pancreatitis. Gastroenterology 1999; 116: 1132-40. (Pubitemid 29203023)
14. Czakõ L, Takács T, Hegyi P, et al. Quality of life assessment after pancreatic enzyme replacement therapy in chronic pancreatitis. Can J Gastroenterol 2003; 17: 597-603. (Pubitemid 37428123)
15. Fitzsimmons D, Kahl S, Butturini G, et al. Symptoms and quality of life in chronic pancreatitis assessed by structured interview and the EORTC QLQ-C30 and QLQ-PAN26. Am J Gastroenterol 2005; 100: 918-26. (Pubitemid 40592388)
16. Pezzilli R, Morselli Labate AM, Ceciliato R, et al. Quality of life in patients with chronic pancreatitis. Dig Liver Dis 2005; 37: 181-9. (Pubitemid 41070537)
17. Pezzilli R, Morselli-Labate AM, Frulloni L, et al. The quality of life in patients with chronic pancreatitis evaluated using the SF-12 questionnaire: a comparative study with the SF-36 questionnaire. Dig Liver Dis 2006; 38: 109-15. (Pubitemid 44356144)
18. Wehler M, Nichterlein R, Fischer B, et al. Factors associated with health-related quality of life in chronic pancreatitis. Am J Gastroenterol 2004; 99: 138-46. (Pubitemid 38679115)
19. Meier RF, Beglinger C,. Nutrition in pancreatic diseases. Best Pract Res Clin Gastroenterol 2006; 20: 507-29. (Pubitemid 43872008)
20. Giger U, Stanga Z, DeLegge MH,. Management of chronic pancreatitis. Nutr Clin Pract 2004; 19: 37-49. (Pubitemid 38209494)
21. Detsky AS, McLaughlin JR, Baker JP, et al. What is subjective global assessment of nutritional status? JPEN J Parenter Enteral Nutr 1987; 11: 8-13. (Pubitemid 17009508)
22. Gudny Geirsdottir O, Thorsdottir I,. Nutritional status of cancer patients in chemotherapy; dietary intake, nitrogen balance and screening. Food Nutr Res 2008; 52.
23. Brady MS, Garson JL, Krug SK, et al. An enteric-coated high-buffered pancrelipase reduces steatorrhea in patients with cystic fibrosis: a prospective, randomized study. J Am Diet Assoc 2006; 106: 1181-6. (Pubitemid 44079970)
24. Colombo C, Fredella C, Russo MC, et al. Efficacy and tolerability of Creon for Children in infants and toddlers with pancreatic exocrine insufficiency caused by cystic fibrosis: an open-label, single-arm, multicenter study. Pancreas 2009; 38: 693-9.
25. Domínguez-Muñoz JE, Iglesias-García J, Iglesias-Rey M, Figueiras A, Vilariño-Insua M,. Effect of the administration schedule on the therapeutic efficacy of oral pancreatic enzyme supplements in patients with exocrine pancreatic insufficiency: a randomized, three-way crossover study. Aliment Pharmacol Ther 2005; 21: 993-1000. (Pubitemid 40529733)
26. Graff GR, Maguiness K, McNamara J, et al. Efficacy and tolerability of a new formulation of pancrelipase delayed-release capsules in children aged 7 to 11 years with exocrine pancreatic insufficiency and cystic fibrosis: a multicenter, randomized, double-blind, placebo-controlled, two-period crossover, superiority study. Clin Ther 2010; 32: 89-103.
27. Graff GR, McNamara J, Royall J, Caras S, Forssmann K,. Safety and tolerability of a new formulation of pancrelipase delayed-release capsules (CREON) in children under seven years of age with exocrine pancreatic insufficiency due to cystic fibrosis: an open-label, multicentre, single-treatment-arm study. Clin Drug Investig 2010; 30: 351-64.
28. Konstan MW, Stern RC, Trout JR, et al. Ultrase MT12 and Ultrase MT20 in the treatment of exocrine pancreatic insufficiency in cystic fibrosis: safety and efficacy. Aliment Pharmacol Ther 2004; 20: 1365-71. (Pubitemid 40040084)
29. Munck A, Duhamel JF, Lamireau T, et al. Pancreatic enzyme replacement therapy for young cystic fibrosis patients. J Cyst Fibros 2009; 8: 14-8.
30. Neoptolemos JP, Ghaneh P, Andren-Sandberg A, et al. Treatment of pancreatic exocrine insufficiency after pancreatic resection. Results of a randomized, double-blind, placebo-controlled, crossover study of high vs standard dose pancreatin. Int J Pancreatol 1999; 25: 171-80. (Pubitemid 29379959)
31. Safdi M, Bekal PK, Martin S, Saeed ZA, Burton F, Toskes PP,. The effects of oral pancreatic enzymes (Creon 10 capsule) on steatorrhea: a multicenter, placebo-controlled, parallel group trial in subjects with chronic pancreatitis. Pancreas 2006; 33: 156-62. (Pubitemid 44174563)
32. Stern RC, Eisenberg JD, Wagener JS, et al. A comparison of the efficacy and tolerance of pancrelipase and placebo in the treatment of steatorrhea in cystic fibrosis patients with clinical exocrine pancreatic insufficiency. Am J Gastroenterol 2000; 95: 1932-8.
33. Trapnell BC, Maguiness K, Graff GR, Boyd D, Beckmann K, Caras S,. Efficacy and safety of Creon 24,000 in subjects with exocrine pancreatic insufficiency due to cystic fibrosis. J Cyst Fibros 2009; 8: 370-7.
34. Waljee AK, Dimagno MJ, Wu BU, Schoenfeld PS, Conwell DL,. Systematic review: pancreatic enzyme treatment of malabsorption associated with chronic pancreatitis. Aliment Pharmacol Ther 2009; 29: 235-46.
35. U.S. Food and Drug Administration. FDA requires pancreatic extract manufacturers to submit marketing applications. Available at:. Accessed September 6, 2010.
36. Whitcomb DC, Lehman GA, Vasileva G, et al. Pancrelipase delayed-release capsules (CREON) for exocrine pancreatic insufficiency due to chronic pancreatitis or pancreatic surgery: a double-blind randomized trial. Am J Gastroenterol 2010; 105: 2276-86.
37. Domínguez-Muñoz JE, Iglesias-García J, Vilariño-Insua M, Iglesias-Rey M,. 13C-mixed triglyceride breath test to assess oral enzyme substitution therapy in patients with chronic pancreatitis. Clin Gastroenterol Hepatol 2007; 5: 484-8. (Pubitemid 46575367)
38. O'Keefe SJ, Cariem AK, Levy M,. The exacerbation of pancreatic endocrine dysfunction by potent pancreatic exocrine supplements in patients with chronic pancreatitis. J Clin Gastroenterol 2001; 32: 319-23. (Pubitemid 32231727)
39. DiMagno MJ, Dimagno EP,. Chronic pancreatitis. Curr Opin Gastroenterol 2006; 22: 487-97.